Literature DB >> 12463886

A semantic normal form for clinical drugs in the UMLS: early experiences with the VANDF.

Stuart J Nelson1, Steven H Brown, Mark S Erlbaum, Nels Olson, Tammy Powell, Brian Carlsen, John Carter, Mark S Tuttle, William T Hole.   

Abstract

A semantic normal form (SNF) for a clinical drug, designed to represent the meaning of an expression typically seen in a practitioner's medication order, has been developed and is being created in the UMLS Metathesaurus. The long term goal is to establish a relationship for every concept in the Metathesaurus with semantic type "clinical drug" with one or more of these semantic normal forms. First steps have been taken using the Veterans Administration National Drug File (VANDF). 70% of the entries in the VANDF could be parsed algorithmically into the SNF. Next steps include parsing other drug vocabularies included in the UMLS Metathesaurus and performing human review of the parsed vocabularies. After machine parsed forms have been merged in the Metathesaurus Information Database (MID), editors will be able to edit matched SNFs for accuracy and establish relationships and relationship attributes with other clinical drug concepts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12463886      PMCID: PMC2244318     

Source DB:  PubMed          Journal:  Proc AMIA Symp        ISSN: 1531-605X


  3 in total

1.  Discovering missed synonymy in a large concept-oriented Metathesaurus.

Authors:  W T Hole; S Srinivasan
Journal:  Proc AMIA Symp       Date:  2000

2.  The Unified Medical Language System.

Authors:  D A Lindberg; B L Humphreys; A T McCray
Journal:  Methods Inf Med       Date:  1993-08       Impact factor: 2.176

3.  Merging terminologies.

Authors:  M S Tuttle; O N Suarez-Munist; N E Olson; D D Sherertz; W D Sperzel; M S Erlbaum; L F Fuller; W T Hole; S J Nelson; W G Cole
Journal:  Medinfo       Date:  1995
  3 in total
  16 in total

1.  Adequacy of representation of the National Drug File Reference Terminology Physiologic Effects reference hierarchy for commonly prescribed medications.

Authors:  S Trent Rosenbloom; Joseph Awad; Ted Speroff; Peter L Elkin; Russell Rothman; Anderson Spickard; Josh Peterson; Brent A Bauer; Dietland L Wahner-Roedler; Mark Lee; William M Gregg; Kevin B Johnson; Jim Jirjis; Mark S Erlbaum; John S Carter; Michael J Lincoln; Steven H Brown
Journal:  AMIA Annu Symp Proc       Date:  2003

2.  Integrating pharmacokinetics knowledge into a drug ontology: as an extension to support pharmacogenomics.

Authors:  C G Chute; J S Carter; M S Tuttle; M Haber; S H Brown
Journal:  AMIA Annu Symp Proc       Date:  2003

3.  A drug database model as a central element for computer-supported dose adjustment within a CPOE system.

Authors:  Peter Martin; Walter E Haefeli; Meret Martin-Facklam
Journal:  J Am Med Inform Assoc       Date:  2004-06-07       Impact factor: 4.497

4.  Analyzing categorical information in two publicly available drug terminologies: RxNorm and NDF-RT.

Authors:  Jyotishman Pathak; Christopher G Chute
Journal:  J Am Med Inform Assoc       Date:  2010 Jul-Aug       Impact factor: 4.497

5.  Achievable steps toward building a National Health Information infrastructure in the United States.

Authors:  William W Stead; Brian J Kelly; Robert M Kolodner
Journal:  J Am Med Inform Assoc       Date:  2004-11-23       Impact factor: 4.497

6.  Biomedical ontologies in action: role in knowledge management, data integration and decision support.

Authors:  O Bodenreider
Journal:  Yearb Med Inform       Date:  2008

7.  Assessing the impact of HL7/FDA Structured Product Label (SPL) content for medication knowledge management.

Authors:  Gunther Schadow
Journal:  AMIA Annu Symp Proc       Date:  2007-10-11

8.  Extraction and mapping of drug names from free text to a standardized nomenclature.

Authors:  Matthew A Levin; Marina Krol; Ankur M Doshi; David L Reich
Journal:  AMIA Annu Symp Proc       Date:  2007-10-11

9.  Structured product labeling improves detection of drug-intolerance issues.

Authors:  Gunther Schadow
Journal:  J Am Med Inform Assoc       Date:  2008-10-24       Impact factor: 4.497

10.  Normalized names for clinical drugs: RxNorm at 6 years.

Authors:  Stuart J Nelson; Kelly Zeng; John Kilbourne; Tammy Powell; Robin Moore
Journal:  J Am Med Inform Assoc       Date:  2011-04-21       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.